midazolam has been researched along with Basal Ganglia Diseases in 3 studies
Midazolam: A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH.
midazolam : An imidazobenzodiazepine that is 4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted by a methyl, 2-fluorophenyl and chloro groups at positions 1, 6 and 8, respectively.
Basal Ganglia Diseases: Diseases of the BASAL GANGLIA including the PUTAMEN; GLOBUS PALLIDUS; claustrum; AMYGDALA; and CAUDATE NUCLEUS. DYSKINESIAS (most notably involuntary movements and alterations of the rate of movement) represent the primary clinical manifestations of these disorders. Common etiologies include CEREBROVASCULAR DISORDERS; NEURODEGENERATIVE DISEASES; and CRANIOCEREBRAL TRAUMA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| McConn, MM | 1 |
| Gundy, JT | 1 |
| Karan, SB | 1 |
| Lindenmuth, DM | 1 |
| Prommer, EE | 1 |
| Brown, DJ | 1 |
| McArthur, D | 1 |
| Moulsdale, H | 1 |
3 other studies available for midazolam and Basal Ganglia Diseases
| Article | Year |
|---|---|
Adverse Drug Reaction: Midazolam-Induced Extrapyramidal Symptoms: A Case Report.
Topics: Basal Ganglia Diseases; Brachial Plexus Block; Female; Flumazenil; Fracture Fixation, Internal; GABA | 2020 |
Midazolam-induced extrapyramidal side effects.
Topics: Aged, 80 and over; Anti-Anxiety Agents; Basal Ganglia Diseases; Humans; Infusions, Parenteral; Male; | 2008 |
Subcutaneous midazolam as a cause of extrapyramidal side effects in a patient with prostate cancer.
Topics: Aged, 80 and over; Anti-Anxiety Agents; Basal Ganglia Diseases; Humans; Infusions, Parenteral; Male; | 2007 |